Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15


Melatonin modulates dysregulated circadian clocks in mice with diethylnitrosamine-induced hepatocellular carcinoma.

Sánchez DI, González-Fernández B, Crespo I, San-Miguel B, Álvarez M, González-Gallego J, Tuñón MJ.

J Pineal Res. 2018 Oct;65(3):e12506. doi: 10.1111/jpi.12506. Epub 2018 May 28.


Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines.

Ceballos MP, Decándido G, Quiroga AD, Comanzo CG, Livore VI, Lorenzetti F, Lambertucci F, Chazarreta-Cifre L, Banchio C, Alvarez ML, Mottino AD, Carrillo MC.

Toxicol Lett. 2018 Jun 1;289:63-74. doi: 10.1016/j.toxlet.2018.03.011. Epub 2018 Mar 12.


Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress.

Li J, Huang Q, Long X, Guo X, Sun X, Jin X, Li Z, Ren T, Yuan P, Huang X, Zhang H, Xing J.

Oncogene. 2017 Aug 24;36(34):4901-4912. doi: 10.1038/onc.2017.98. Epub 2017 Apr 24.


Caloric restriction delays early phases of carcinogenesis via effects on the tissue microenvironment.

Cadoni E, Marongiu F, Fanti M, Serra M, Laconi E.

Oncotarget. 2017 May 30;8(22):36020-36032. doi: 10.18632/oncotarget.16421.


SIRT1/PGC1α-Dependent Increase in Oxidative Phosphorylation Supports Chemotherapy Resistance of Colon Cancer.

Vellinga TT, Borovski T, de Boer VC, Fatrai S, van Schelven S, Trumpi K, Verheem A, Snoeren N, Emmink BL, Koster J, Rinkes IH, Kranenburg O.

Clin Cancer Res. 2015 Jun 15;21(12):2870-9. doi: 10.1158/1078-0432.CCR-14-2290. Epub 2015 Mar 16.


Synergic chemoprevention with dietary carbohydrate restriction and supplementation of AMPK-activating phytochemicals: the role of SIRT1.

Lee JD, Choi MA, Ro SW, Yang WI, Cho AE, Ju HL, Baek S, Chung SI, Kang WJ, Yun M, Park JH.

Eur J Cancer Prev. 2016 Jan;25(1):54-64. doi: 10.1097/CEJ.0000000000000141.


DBC1 functions as a tumor suppressor by regulating p53 stability.

Qin B, Minter-Dykhouse K, Yu J, Zhang J, Liu T, Zhang H, Lee S, Kim J, Wang L, Lou Z.

Cell Rep. 2015 Mar 3;10(8):1324-34. doi: 10.1016/j.celrep.2015.01.066. Epub 2015 Feb 26.


The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma.

Wang J, Tang X, Weng W, Qiao Y, Lin J, Liu W, Liu R, Ma L, Yu W, Yu Y, Pan Q, Sun F.

Oncogene. 2015 Nov 19;34(47):5781-95. doi: 10.1038/onc.2015.36. Epub 2015 Mar 2.


The effect of alcohol on Sirt1 expression and function in animal and human models of hepatocellular carcinoma (HCC).

Thompson KJ, Humphries JR, Niemeyer DJ, Sindram D, McKillop IH.

Adv Exp Med Biol. 2015;815:361-73. doi: 10.1007/978-3-319-09614-8_21.


Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model.

Lou W, Chen Q, Ma L, Liu J, Yang Z, Shen J, Cui Y, Bian XW, Qian C.

J Mol Med (Berl). 2013 Jun;91(6):715-25. doi: 10.1007/s00109-012-0985-x. Epub 2013 Jan 6.


Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model.

Lin HC, Chen YF, Hsu WH, Yang CW, Kao CH, Tsai TF.

Cancer Prev Res (Phila). 2012 Jul;5(7):952-62. doi: 10.1158/1940-6207.CAPR-12-0001. Epub 2012 Jun 1.


[Sirtuin 1, hepatic steatosis and liver cancer].

Gilgenkrantz H, Perret C.

Med Sci (Paris). 2012 Mar;28(3):269-71. doi: 10.1051/medsci/2012283014. Epub 2012 Apr 6. French. No abstract available.


Inhibition of SIRT1 impairs the accumulation and transcriptional activity of HIF-1α protein under hypoxic conditions.

Laemmle A, Lechleiter A, Roh V, Schwarz C, Portmann S, Furer C, Keogh A, Tschan MP, Candinas D, Vorburger SA, Stroka D.

PLoS One. 2012;7(3):e33433. doi: 10.1371/journal.pone.0033433. Epub 2012 Mar 30.


Gene expression and mutation assessment provide clues of genetic and epigenetic mechanisms in liver tumors of oxazepam-exposed mice.

Lahousse SA, Hoenerhoff M, Collins J, Ton TV, Masinde T, Olson D, Rebolloso Y, Koujitani T, Tomer KB, Hong HH, Bucher J, Sills RC.

Vet Pathol. 2011 Jul;48(4):875-84. doi: 10.1177/0300985810390019. Epub 2010 Dec 7.


The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation.

Pogribny IP, Muskhelishvili L, Tryndyak VP, Beland FA.

Toxicol Appl Pharmacol. 2009 Mar 15;235(3):305-11. doi: 10.1016/j.taap.2008.12.021. Epub 2009 Jan 6.


Supplemental Content

Loading ...
Support Center